Colfosceril Palmitate/Cetyl Alcohol/Tyloxapol

棕榈胆磷/鲸蜡醇/泰洛沙泊

Report date: 2022/01/14 13:23:58

Base Information

Drug NameColfosceril Palmitate/Cetyl Alcohol/Tyloxapol
Drug Alias Name棕榈胆磷●鲸蜡醇●泰洛沙泊Colfosceril Palmitate●Cetyl Alcohol●Tyloxapol棕榈胆磷-鲸蜡醇-泰洛沙泊Colfosceril Palmitate-Cetyl Alcoho-TyloxapolExosurf Neonatal
ClassificationSmall molecules
Mechanisms of ActionLipoprotein lipase inhibitors
TargetsLipoprotein lipase
Therapy Area/IndicationsRespiratory Distress Syndrome, Adult
Global Approved IndicationsRespiratory Distress Syndrome, Adult
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1990/08/02
Country/TerritoryUnited States
CombinationsYes Colfosceril PalmitateTyloxapol
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsRespiratory Distress Syndrome, Adult

Other Information

ATC CodeN/A
Related LinksN/A